116 related articles for article (PubMed ID: 23567490)
21. A common gene variant in PLS3 predicts colon cancer recurrence in women.
Szkandera J; Winder T; Stotz M; Weissmueller M; Langsenlehner T; Pichler M; Samonigg H; Renner W; Gerger A; Absenger G
Tumour Biol; 2013 Aug; 34(4):2183-8. PubMed ID: 23549633
[TBL] [Abstract][Full Text] [Related]
22. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
Hsia TC; Liu CJ; Lin CH; Chang WS; Chu CC; Hang LW; Lee HZ; Lo WC; Bau DT
Anticancer Res; 2011 Oct; 31(10):3601-5. PubMed ID: 21965784
[TBL] [Abstract][Full Text] [Related]
23. Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.
Szkandera J; Absenger G; Pichler M; Stotz M; Langsenlehner T; Samonigg H; Renner W; Gerger A
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1457-64. PubMed ID: 23793229
[TBL] [Abstract][Full Text] [Related]
24. The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database.
Cheung WY; Shi Q; O'Connell M; Cassidy J; Blanke CD; Kerr DJ; Meyers J; Van Cutsem E; Alberts SR; Yothers G; Sargent DJ;
Clin Colorectal Cancer; 2013 Sep; 12(3):179-87. PubMed ID: 23810482
[TBL] [Abstract][Full Text] [Related]
25. Significant Association of
Hsu PC; Pei JS; Chen CC; Chang WS; Chin YT; Huang TL; Yang JS; Wang YC; Chen JC; Hsu YN; Tsai CW; Bau DT
Anticancer Res; 2021 Oct; 41(10):4801-4806. PubMed ID: 34593429
[TBL] [Abstract][Full Text] [Related]
26. Significant Association of Cyclin D1 Promoter Genotypes With Asthma Susceptibility in Taiwan.
Li CH; Chiu KL; Hsia TC; Shen TC; Chen LH; Yu CC; Mong MC; Chang WS; Tsai CW; Bau DT
In Vivo; 2021; 35(4):2041-2046. PubMed ID: 34182479
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
[TBL] [Abstract][Full Text] [Related]
28. Association of CCND1 (c.723G > A, rs9344) variant with elevated risk of breast carcinoma: a retrospective case-control study.
El-Eshmawy MA; Shahin HE; El-Beltagy NS; Abdel Hamid D; Elfarargy OM; Elsayed DH; Elsaid AM; Elshazli RM; Mohamed NM
Mol Biol Rep; 2023 Mar; 50(3):2015-2024. PubMed ID: 36534235
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.
Wilkinson NW; Yothers G; Lopa S; Costantino JP; Petrelli NJ; Wolmark N
Ann Surg Oncol; 2010 Apr; 17(4):959-66. PubMed ID: 20082144
[TBL] [Abstract][Full Text] [Related]
30. The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.
Labonte MJ; Wilson PM; Yang D; Zhang W; Ladner RD; Ning Y; Gerger A; Bohanes PO; Benhaim L; El-Khoueiry R; El-Khoueiry A; Lenz HJ
Ann Oncol; 2012 Jun; 23(6):1455-64. PubMed ID: 21989330
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
Zhao S; Jiang T; Tang H; Cui F; Liu C; Guo F; Lu H; Xue Y; Jiang W; Peng Z; Yan D
J Gastroenterol Hepatol; 2015 Apr; 30(4):680-8. PubMed ID: 25238407
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
[TBL] [Abstract][Full Text] [Related]
34. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
[TBL] [Abstract][Full Text] [Related]
35. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
[TBL] [Abstract][Full Text] [Related]
36. Significance of cyclin D1 polymorphisms in patients with head and neck cancer.
Sabir M; Baig RM; Mahjabeen I; Kayani MA
Int J Biol Markers; 2013 Apr; 28(1):49-55. PubMed ID: 23125009
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.
Custodio A; Moreno-Rubio J; Aparicio J; Gallego-Plazas J; Yaya R; Maurel J; Rodríguez-Salas N; Burgos E; Ramos D; Calatrava A; Andrada E; Díaz-López E; Sánchez A; Madero R; Cejas P; Feliu J
Mol Cancer Ther; 2014 Sep; 13(9):2226-37. PubMed ID: 24980946
[TBL] [Abstract][Full Text] [Related]
38. [Impact of CCND1 A870G polymorphism on acute adverse events in postoperative rectal cancer patients treated with adjuvant concurrent chemoradiotherapy].
Qiao Y; Ren H; Huang Y; DU ZL; Yu DK; Jin J; Li YX; Lin DX; Tan W
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):268-72. PubMed ID: 23985254
[TBL] [Abstract][Full Text] [Related]
39. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
[TBL] [Abstract][Full Text] [Related]
40. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
